These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12166653)

  • 1. Molecular and structural studies of the GM2 gangliosidosis 0 variant.
    Sakuraba H; Matsuzawa F; Aikawa S; Doi H; Kotani M; Lin H; Ohno K; Tanaka A; Yamada H; Uyama E
    J Hum Genet; 2002; 47(4):176-83. PubMed ID: 12166653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of the GM2 gangliosidosis B variant.
    Matsuzawa F; Aikawa S; Sakuraba H; Lan HT; Tanaka A; Ohno K; Sugimoto Y; Ninomiya H; Doi H
    J Hum Genet; 2003; 48(11):582-9. PubMed ID: 14577003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Western blotting analysis of the beta-hexosaminidase alpha- and beta-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis.
    Utsumi K; Tsuji A; Kase R; Tanaka A; Tanaka T; Uyama E; Ozawa T; Sakuraba H; Komaba Y; Kawabe M; Iino Y; Katayama Y
    Acta Neurol Scand; 2002 Jun; 105(6):427-30. PubMed ID: 12027830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the molecular mechanism of GM(2) gangliosidosis].
    Hou L; Kousaku O
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):103-6. PubMed ID: 12673576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant.
    Casal JA; Pérez LF; Tutor JC
    Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant.
    Martin DR; Krum BK; Varadarajan GS; Hathcock TL; Smith BF; Baker HJ
    Exp Neurol; 2004 May; 187(1):30-7. PubMed ID: 15081585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation (C522Y) is present in the beta-hexosaminidase beta-subunit gene of a Japanese patient with infantile Sandhoff disease.
    Kuroki Y; Itoh K; Nadaoka Y; Tanaka T; Sakuraba H
    Biochem Biophys Res Commun; 1995 Jul; 212(2):564-71. PubMed ID: 7626071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in GM2-gangliosidosis B1 variant.
    Ohno K; Suzuki K
    J Neurochem; 1988 Jan; 50(1):316-8. PubMed ID: 2961848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of human GM2-activator protein with a novel beta-cup topology.
    Wright CS; Li SC; Rastinejad F
    J Mol Biol; 2000 Dec; 304(3):411-22. PubMed ID: 11090283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic correction in microglia derived from Sandhoff disease model mice.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
    J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.
    Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ
    Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural bases of GM1 gangliosidosis and Morquio B disease.
    Morita M; Saito S; Ikeda K; Ohno K; Sugawara K; Suzuki T; Togawa T; Sakuraba H
    J Hum Genet; 2009 Sep; 54(9):510-5. PubMed ID: 19644515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis.
    Kawashima N; Tsuji D; Okuda T; Itoh K; Nakayama K
    J Neurochem; 2009 Nov; 111(4):1031-41. PubMed ID: 19765188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enzyme-binding region of human GM2-activator protein.
    Wendeler M; Werth N; Maier T; Schwarzmann G; Kolter T; Schoeniger M; Hoffmann D; Lemm T; Saenger W; Sandhoff K
    FEBS J; 2006 Mar; 273(5):982-91. PubMed ID: 16478472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene.
    Akeboshi H; Kasahara Y; Tsuji D; Itoh K; Sakuraba H; Chiba Y; Jigami Y
    Glycobiology; 2009 Sep; 19(9):1002-9. PubMed ID: 19506294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe subacute GM2 gangliosidosis caused by an apparently silent HEXA mutation (V324V) that results in aberrant splicing and reduced HEXA mRNA.
    Wicklow BA; Ivanovich JL; Plews MM; Salo TJ; Noetzel MJ; Lueder GT; Cartegni L; Kaback MM; Sandhoff K; Steiner RD; Triggs-Raine BL
    Am J Med Genet A; 2004 Jun; 127A(2):158-66. PubMed ID: 15108204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late infantile and juvenile form of GM2-gangliosidosis variant B1].
    Eirís J; Chabás A; Coll MJ; Castro-Gago M
    Rev Neurol; 1999 Sep 1-15; 29(5):435-8. PubMed ID: 10584247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Juvenile GM2 gangliosidosis with progressive spinal muscular atrophy onset].
    Rondot P; Navon R; Eymard B; Fardeau M; Turpin JC; Lefevre M; Bathien N; Wu Y; Baumann N
    Rev Neurol (Paris); 1997 Mar; 153(2):120-3. PubMed ID: 9296123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.